NCT01942681

Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride

Multi-institution Study on Efficacy and Safety of Propiverine Hydrochloride for Female Patients With Urge and Stress Urinary Incontinence

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 62 (actual)
• Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
• Sex: Female
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the efficacy and safety that the occurrence of incontinence is significantly decrease using the propiverine hydrochloride for 200 female patients with mixed (stress and urge) urinary incontinence in one week during a twelve-week treatment period.

Conditions

• Urinary Incontinence

Interventions

Type	Name	Description
DRUG	Propiverine Hydrochloride	Administrate Propiverine Hydrochloride for 12 weeks

Timeline

• Start date: 2013-09-01
• Primary completion: 2015-06-01
• Completion: 2015-06-01
• First posted: 2013-09-16
• Last updated: 2015-07-15

Locations

1 site across 1 country: Japan